- Home
- MREO vs BGH Comparison
MREO vs BGH Comparison
Compare MREO & BGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- BGH
- Stock Information
- Founded
- MREO 2015
- BGH 2012
- Country
- MREO United Kingdom
- BGH United States
- Employees
- MREO N/A
- BGH N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- BGH Investment Managers
- Sector
- MREO Health Care
- BGH Finance
- Exchange
- MREO Nasdaq
- BGH Nasdaq
- Market Cap
- MREO 369.2M
- BGH 318.8M
- IPO Year
- MREO N/A
- BGH N/A
- Fundamental
- Price
- MREO $2.26
- BGH $15.12
- Analyst Decision
- MREO Strong Buy
- BGH
- Analyst Count
- MREO 7
- BGH 0
- Target Price
- MREO $7.71
- BGH N/A
- AVG Volume (30 Days)
- MREO 1.2M
- BGH 61.5K
- Earning Date
- MREO 03-26-2025
- BGH 01-01-0001
- Dividend Yield
- MREO N/A
- BGH 10.06%
- EPS Growth
- MREO N/A
- BGH N/A
- EPS
- MREO N/A
- BGH N/A
- Revenue
- MREO N/A
- BGH N/A
- Revenue This Year
- MREO N/A
- BGH N/A
- Revenue Next Year
- MREO $69.09
- BGH N/A
- P/E Ratio
- MREO N/A
- BGH N/A
- Revenue Growth
- MREO N/A
- BGH N/A
- 52 Week Low
- MREO $2.16
- BGH $11.92
- 52 Week High
- MREO $5.02
- BGH $14.50
- Technical
- Relative Strength Index (RSI)
- MREO 33.19
- BGH 32.45
- Support Level
- MREO $2.23
- BGH $15.08
- Resistance Level
- MREO $2.73
- BGH $15.35
- Average True Range (ATR)
- MREO 0.14
- BGH 0.14
- MACD
- MREO -0.01
- BGH 0.01
- Stochastic Oscillator
- MREO 7.89
- BGH 37.50
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About BGH Barings Global Short Duration High Yield Fund of Beneficial Interests
Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.